AKT1 and neoplasm: One of the genes, LGR6 (Leucine-Rich Repeat Containing G Protein-Coupled Receptor 6) regulates the phosphoinositide 3-kinase/AKT signaling pathway and plays a tumor-promoting role in CRC development indicating that it might be a potential diagnostic and prognostic biomarker for CRC [42].